Evidence map›Paper›PMID 37888472›Full record

ArticleMarine drugs2023

Tânia Leandro, Marco Teles, Joana S Gomes-Dias, Mafalda Marques, Cristina M R Rocha, M Manuela R da Fonseca, M Teresa Cesário

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. How to fight acute sun damage? Current skin care strategies.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tânia LeandroIBB-Institute for Bioengineering and Biosciences, Bioengineering Department, Instituto Superior Técnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
Marco TelesIBB-Institute for Bioengineering and Biosciences, Bioengineering Department, Instituto Superior Técnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
Joana S Gomes-DiasCEB-Centre of Biological Engineering, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.
Mafalda MarquesIBB-Institute for Bioengineering and Biosciences, Bioengineering Department, Instituto Superior Técnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
Cristina M R RochaCEB-Centre of Biological Engineering, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0003-4687-0266
M Manuela R da FonsecaIBB-Institute for Bioengineering and Biosciences, Bioengineering Department, Instituto Superior Técnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
M Teresa CesárioIBB-Institute for Bioengineering and Biosciences, Bioengineering Department, Instituto Superior Técnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.ORCID 0000-0002-2550-2133
University of Lisbon · PTUniversity of Minho · PTInstitute for Biotechnology and Bioengineering · PT

Funding

Fundação para a Ciência e Tecnologia PTDC/BII-BIO/29242/2017
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ulva3-Hydroxybutyric AcidGluconatesPolyestersPolyhydroxybutyrates3-Hydroxybutyric AcidGluconatesgluconic acidpoly-beta-hydroxybutyratePolyestersPolyhydroxybutyrates2-oxoglutaric acidfunctional ingredientsgluconic acidHalomonas elongatapoly(3-hydroxybutyrate)Ulva rigida

Identifiers

PMID37888472
PMCPMC10608297
OpenAlexW4387639024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.